(30)Commission Implementing Regulation (EU) 2023/918note extended the approval period of the active substance boscalid until 15 April 2026, and the approval periods of the active substances penoxsulam and proquinazid until 15 May 2026.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.